Researchmoz Global Pvt. Ltd.

Disposable Auto-Injectors to Lead the Way for Global Market They Gain Preference for Being Convenient


Albany, NY -- (SBWIRE) -- 10/02/2018 -- has added a new research report to its repository. The publication, titled "Auto-injectors Market, Global Forecast by Application (Anaphylaxis, Multiple Sclerosis, etc.), Product Types, Usability, Distribution Channels, Regions & Companies", sheds light on the market forces shaping the trajectory of the market. Analysts have used primary and secondary research methodologies to give the readers an accurate and exact interpretation and estimation of the course global auto-injectors market will take over the forecast period.

The research report predicts that the global auto-injectors market will cross valuation of US$5 bn by the end of 2024. The demand for auto-injectors is expected to rise in the coming years as they enable simple self-administration, which has drastically reduced the cost of drug delivery. Analysts point that increasing incidences of anaphylaxis and multiple sclerosis has been the primary growth driver for the global auto-injectors market. Ease of self-medication, growing investments in research and development of drug delivery systems, and increasing demand for targeted treatments for chronic diseases are expected to spur market growth in the coming years.

Get a sample PDF:

On the basis of usability, the global market for auto-injectors is segmented into reusable and disposable. Out of the two, the demand for disposable auto-injectors is expected to remain higher. Analysts state that the disposable auto-injectors segment will hold a lion's share in the global auto-injectors by the end of the forecast period. This dominance will be due to the low risk of infection that disposable auto-injectors ensure. Their ease of usage is also expected to garner them significant traction during the forecast years.

In terms of geography, the global auto-injectors market is segmented into Asia Pacific, Europe, North America, and the Middle East and Africa. Out of these, the North America auto-injectors market is expected to lead the global market. The region's spot at the top will be attributable to the advanced healthcare infrastructure, adoption of sophisticated medical technologies, growing demand for quality products, and supportive reimbursement policies. On the other hand, Asia Pacific is also projected to show a fast growth rate in the coming years as the emerging economies in the region make steady progress. Rise of medical tourism in developing economy of India is projected to favor the regional market's growth.

The key players operating in the global auto-injectors market are Antares Pharma, Mylan N.V, Amgen Inc., Novartis AG, and Bayer AG. The research report has profiled these players and provided a detailed scope of the competitive landscape. The publication includes an in-depth analysis of the financial outlook, research and development strategies, and business and marketing strategies of these players. Analysts have also included Porter's five forces analysis to give the readers an in-depth analysis of the intensity of the competitive rivalry. Researchers have also discussed the emerging trends in the global auto-injectors market and the ones that could prove to be lucrative business options.